Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.

Established in 1963, this manufacturer specializes in producing hormones, steroids, and other pharmaceutical products in various dosage forms, including tablets, capsules, injections, and ophthalmic drops. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple international regulatory authorities, including the U.S. FDA, the Therapeutic Goods Administration (TGA) of Australia, and the Malta Medicines Authority (European Union). The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in multiple countries worldwide.

Established in 2016, this WHO-GMP certified manufacturer specializes in the production and export of pharmaceutical, nutraceutical, and ayurvedic products, including tablets, capsules, syrups, and injections. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates state-of-the-art manufacturing facilities adhering to stringent GMP guidelines. Its products are distributed across multiple countries worldwide, with registrations in regions such as the Dominican Republic, Philippines, Myanmar, Uzbekistan, Turkmenistan, Iraq, and Kuwait.